Loading...
XJPX
7707
Market cap32mUSD
Dec 05, Last price  
187.00JPY
1D
-2.60%
1Q
-10.95%
Jan 2017
-54.05%
IPO
131.58%
Name

Precision System Science Co Ltd

Chart & Performance

D1W1MN
XJPX:7707 chart
P/E
—
P/S
1.08
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.19%
Rev. gr., 5y
-1.52%
Revenues
4.69b
+17.91%
3,397,932,0003,802,466,0005,637,771,0003,142,760,0003,520,274,0004,029,396,0003,921,722,0005,143,465,0004,458,411,0003,847,021,0003,641,164,0004,381,442,0005,067,231,0009,298,741,0007,434,287,0005,278,321,0003,979,954,0004,692,629,000
Net income
-253m
L-77.43%
-400,557,00073,599,000549,992,000-366,678,000-189,057,0001,014,386,000611,958,000-215,220,000-1,582,050,000-555,218,000-457,616,000130,318,000-114,275,000795,985,00045,337,000-1,324,290,000-1,121,480,000-253,097,000
CFO
96m
P
199,351,000339,751,000407,281,000-403,391,000-396,598,000-35,239,000-822,599,000-1,362,603,00072,149,000-802,766,000-32,812,000-403,711,000-21,452,000-280,966,000869,161,000-6,746,000-106,801,00095,828,000
Dividend
Jun 29, 20215 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products in Japan and internationally. The company manufactures and sells plastic consumables, which are used in automated systems/instruments, as well as reagents; and automated nucleic acid extraction and veterinary biochemical analysis systems. It also offers geneLEAD, an instrument for molecular testing; and engages in the research and development, and practical application of in vitro diagnosis testing market, including genetic and protein tests. Precision System Science Co., Ltd. was founded in 1985 and is headquartered in Matsudo, Japan.
URL
https://www.pss.co.jp/
IPO date
Feb 01, 2001
Employees
196
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT